Uptown Drug Co. v. CVS Caremark Corp.

962 F. Supp. 2d 1172, 2013 WL 3821570, 2013 U.S. Dist. LEXIS 102265
CourtDistrict Court, N.D. California
DecidedJuly 22, 2013
DocketNo. 12-cv-06559-JST
StatusPublished
Cited by11 cases

This text of 962 F. Supp. 2d 1172 (Uptown Drug Co. v. CVS Caremark Corp.) is published on Counsel Stack Legal Research, covering District Court, N.D. California primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Uptown Drug Co. v. CVS Caremark Corp., 962 F. Supp. 2d 1172, 2013 WL 3821570, 2013 U.S. Dist. LEXIS 102265 (N.D. Cal. 2013).

Opinion

ORDER GRANTING IN PART AND DENYING IN PART MOTION TO COMPEL ARBITRATION AND TO STAY ACTION AND GRANTING MOTIONS TO SEAL

Re: ECF No. 17, 18, 42

JON S. TIGAR, District Judge.

In this putative class action for violations of the California Uniform Trade Secrets Act and related claims, Defendants move to compel arbitration and to stay the action pending arbitration. Plaintiff Up[1176]*1176town Drug Company, Inc. (“Uptown”) opposes the motion. For the reasons set forth below, the motion to compel arbitration is GRANTED IN PART and DENIED IN PART and the motion to stay the action pending arbitration is GRANTED.

I. BACKGROUND

A. The Parties and Claims

Uptown provides pharmacy services to individuals who participate in certain group health plans. Compl. ¶¶ 1-2, 14. These group health plans provide to customers pharmacy benefits that are sponsored, administered, or insured by pharmacy benefit managers (“PBMs”). Id. ¶ 14.

CVS Caremark is a retail pharmacy chain that competes directly with Uptown.1 Id. ¶ 1. CVS Caremark merged with Care-mark Rx, the second largest PBM in the country, in 2007. Id. As a PBM, Care-mark Rx fills prescriptions, processes prescription drug claims, negotiates discounts with manufacturers, and performs other functions for PBM plan members. Id.

Uptown has a business relationship with Caremark Rx’s PBM branch because many of Uptown’s customers receive drug benefits under PBM prescription plans. Id. This relationship is governed by a provider agreement, which allows Uptown to fill prescriptions for participants in Care-mark’s PBM plans at discounted prices and requires Uptown to disclose certain customer information to Caremark Rx whenever it submits claims for reimbursement.

Uptown has disclosed customer information to Caremark’s PBM operations “in confidence and solely for the purpose of adjudicating [ ] prescription claims.” Caremark Rx allegedly has disclosed this information without authorization to Care-mark’s retail pharmacies, which compete directly with Uptown, for the purpose of marketing products and services to Uptown’s customers. Id. ¶¶ 4, 47, 81. These unauthorized disclosures, which allegedly contravene Caremark’s own internal policies and the Health Insurance Portability and Accountability Act, have resulted in increased revenues for Caremark’s retail pharmacies at the expense of Uptown and other non-CVS pharmacies. Id. ¶¶ 3-6, 63.

Uptown brings this action on its own behalf and on behalf of other similarly situated pharmacies in California against Defendants CVS Caremark, CVS Pharmacy, Caremark Rx, and Caremark, L.L.C. for (1) violations of California’s Uniform Trade Secrets Act (“UTSA”); (2) violations of the unlawful prong of California’s Unfair Competition Law (“UCL”), California Business and Professions Code section 17200; (3) violations of the unfair prong of the UCL; and (4) interference with prospective economic advantage (“IPEA”).2 The gravamen of the complaint is that Defendants’ unauthorized disclosure of non-CVS pharmacies’ customer information constitutes the misappropriation of trade secrets.

B. Provider Agreements and Manuals

In 1995, Uptown entered into an agreement with PCS Health Systems (“the PCS Provider Agreement”), which is a PBM [1177]*1177that ultimately became Caremark PCS Health in 2008 as a result of various acquisitions and mergers.3 Pagnillo Decl. ¶ 14 & Ex. A, ECF No. 18;4 Request for Judicial Notice (“RJN”), Ex. A, B., ECF No. 19.5 The agreement allowed Uptown to be included in PCS Health’s PBM networks. See generally Pagnillo Deck, Ex. A.

PCS Health retained the right to amend the PCS Provider Agreement at any time as long as it gave notice to the pharmacy providers, including Uptown, no less than 30 days before enacting any amendment. Pagnillo Deck, Ex. A ¶ 1.3. The PCS Provider Agreement contained an arbitration clause and incorporated by reference a PCS Manual. See Pagnillo Deck, Ex. A ¶ 9.5 (arbitration clause); id. ¶¶ 1.3, 9.7 (provider manual).

The PCS Provider Agreement and the incorporated PCS Manual have been amended several times as a result of multiple mergers and acquisitions.6 Each time, PCS Health’s successors provided advance notice to provider pharmacies of the amendments.7

The current version of the PCS Provider Agreement and the incorporated PCS Manual is the Caremark Provider Agreement and the 2011 Caremark Provider Manual (“the 2011 Provider Manual”). The 2011 Provider Manual sets forth the rights and obligations of Uptown and Defendants with respect to Uptown’s participation in the networks maintained by Caremark and its affiliates, as well as the terms and conditions for filling prescriptions, submitting claims for reimbursement, and receiving, sorting, and transmitting customer information. Pagnillo Deck, Ex. D at 13-20. Additionally, the 2011 Provider Manual includes provisions that clearly identify Caremark as the party that owns any customer data compiled, utilized, or transmitted in accordance with the Caremark Provider Agreement. See, e.g., Pagnillo Deck, Ex. D at 48 (“Provider agrees that the information contained in the claims systems that was obtained by and through the administration and adjudication of a claim by Provider is the property of Caremark, and Provider agrees not [1178]*1178to claim any right, title, or interest in said information. Caremark has the right to use, reproduce, and adapt any information or data obtained from Provider in any manner deemed appropriate, even if such use is outside the scope of the Provider Agreement, provided such use is in accordance with applicable Law.”); see also id. at 13-20, 38 (providing for the collection, maintenance, transmission, and use of data related to filling prescriptions).

C.The Arbitration Clause

The 2011 Provider Manual contains an arbitration clause under a section entitled “Miscellaneous.” Pagnillo Deck, Ex. D at 50. It provides that:

Any and all disputes in connection with or arising out of the Provider Agreement by the parties will be exclusively settled by arbitration before a single arbitrator in accordance with the Rules of the American Arbitration Association. The arbitrator must follow the rule of Law, and may only award remedies provided for in the Provider Agreement. The award of the arbitrator will be final and binding on the parties, and judgment upon such award may be entered in any court having jurisdiction thereof. Any such arbitration must be conducted in Scottsdale, Arizona, and Provider agrees to such jurisdiction, unless otherwise agreed to by the parties in writing.... Arbitration shall be the exclusive and final remedy for any dispute between the parties in connection with or arising out of the Provider Agreement; provided, however, that nothing in this provision shall prevent either party from seeking injunctive relief for breach of this Provider Agreement in any state or federal court of law.... The terms of this Arbitration section apply notwithstanding any other provision in the Provider Agreement.
Id. (emphasis added).
D.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Apexxus LLC v. OptumRx, Inc.
N.D. California, 2025
Mattson Technology v. Applied Materials
California Court of Appeal, 2023
Platt v. OptumRX CA1/1
California Court of Appeal, 2023
Park Irmat Drug Corp. v. Express Scripts Holding Co.
310 F. Supp. 3d 1002 (E.D. Missouri, 2018)
Waymo LLC v. Uber Technologies, Inc.
870 F.3d 1342 (Federal Circuit, 2017)
Waymo LLC v. Uber Technologies, Inc.
252 F. Supp. 3d 934 (N.D. California, 2017)
Hopkinton Drug, Inc. v. CaremarkPCS, L.L.C.
77 F. Supp. 3d 237 (D. Massachusetts, 2015)
Paduano v. Express Scripts, Inc.
55 F. Supp. 3d 400 (E.D. New York, 2014)

Cite This Page — Counsel Stack

Bluebook (online)
962 F. Supp. 2d 1172, 2013 WL 3821570, 2013 U.S. Dist. LEXIS 102265, Counsel Stack Legal Research, https://law.counselstack.com/opinion/uptown-drug-co-v-cvs-caremark-corp-cand-2013.